Infection chains and evolution rates of hepatitis B virus in cardiac transplant recipients infected nosocomially
Corresponding Author
Dieter R. Petzold
Institute of Virology, Hannover Medical School, Hannover, Germany
Institute of Virology, Hannover Medical School, D-30623 Hannover, Germany===Search for more papers by this authorBernhard Tautz
Institute of Virology, Hannover Medical School, Hannover, Germany
Search for more papers by this authorFriedhelm Wolf
Institute of Virology, Hannover Medical School, Hannover, Germany
Search for more papers by this authorJoachim Drescher
Institute of Virology, Hannover Medical School, Hannover, Germany
Search for more papers by this authorCorresponding Author
Dieter R. Petzold
Institute of Virology, Hannover Medical School, Hannover, Germany
Institute of Virology, Hannover Medical School, D-30623 Hannover, Germany===Search for more papers by this authorBernhard Tautz
Institute of Virology, Hannover Medical School, Hannover, Germany
Search for more papers by this authorFriedhelm Wolf
Institute of Virology, Hannover Medical School, Hannover, Germany
Search for more papers by this authorJoachim Drescher
Institute of Virology, Hannover Medical School, Hannover, Germany
Search for more papers by this authorAbstract
Following an outbreak of hepatitis B virus (HBV) infection amongst immunosuppressed transplant recipients, the complete sequences of the HBV-DNA isolated from nine of the affected patients were determined. The DNA sequences were found to differ from each other by a maximum of three nucleotides and belonged to the same serotype (ayw3). By contrast, the sequences differed by 18 nucleotides from the most similar HBV-DNA sequence published, indicating a common source of infection. The infection chains that have been constructed according to the base differences between the DNAs agreed well with those previously established on the basis of epidemiological data [Drescher et al. (1994) Journal of Hospital Infection 26:81–92]. At least two HBV populations, differing by one or two nucleotides, were detected in four patients, and coexisted for differing periods of time. Mutations of the core and X-peptide were not found. The data were used to calculate evolution rates of HBV DNA, both for HBV persisting within a patient and for infection chains. The rates obtained were of the same order as described previously for immunocompetent patients, indicating that the immunosuppressive medication did not influence the evolution rate. However, the evolution rate was found to decrease with increasing evolution time. J. Med. Virol. 58:1–10, 1999. © 1999 Wiley-Liss, Inc.
REFERENCES
- Barnes WM. 1992. The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion. Gene 112: 29–35. Medline
- Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, Tzakis AG, Schiff ER, Brown NA. 1997. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 349: 20–22. Medline
- Blum HE. 1993. Hepatitis B virus: significance of naturally occurring mutants. Intervirology 35: 40–50. Medline
- Blum HE. 1995. Variants of hepatitis B, C and D viruses: molecular biology and clinical significance. Digestion 56: 85–1995. Medline
- Bowyer SH, van Staden L, Kew MC, Sim JGM. 1997. A unique segment of hepatitis B virus group A genotype identified in isolates from South Africa. J Gen Virol 78: 1719–1729. Medline
- Bozkaya H, Akarca US, Ayola B, Lok ASF. 1997. High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection. J Hepatol 26: 508–516. Medline
- Brind A, Jiang J, Samuel D, Gigou M, Feray C, Bréchot C, Kremsdorf D. 1997. Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. J Hepatol 26: 228–235. Medline
- Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckermann AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336: 325–329. Medline
- Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. 1995. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345: 1406–1407. Medline
- Cong YS, Yao YL, Yang WM, Kuzhandaivelu N, Seto E. 1997. The hepatitis B virus X-associated protein, XAP3, is a protein kinase C-binding protein. J Biol Chem 272: 16482–16489. Medline
- Corpet F. 1989. Multiple sequence alignment with hierarchical clustering. Nucl Acids Res 16: 10881–10890.
- Couroucé-Pauty AM, Plancon A, Soulier JP. 1983. Distribution of HBsAg subtypes in the world. Vox Sanguinis 44: 197–211. Medline
- David E, Garcia AD, Hearing P. 1995. Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation. J Biol Chem 270: 8353–8360. Medline
- Drescher J, Wagner D, Haverich A, Flik J, Stachan-Kunstyr R, Verhagen W, Wagenbreth I. 1994. Nosocomial hepatitis B virus infections in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy. J Hosp Infect 26: 81–92. Medline
- Fortuin M, Karthigesu V, Allison L, Howard C, Hoare S, Mendy M, Whittle HC. 1994. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis 169: 1374–1376. Medline
- Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281: 646–650. Medline
- Girones R, Miller RH. 1989. Mutation rate of the hepadnavirus genome. Virology 170: 595–597. Medline
- Günther S, Li B-C, Miska S, Krüger DH, Meisel H, Will H. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69: 5437–5444. Medline
- Harpaz R, von Seidlen L, Averhoff FM, Tormey MP, Sinha SD, Kotsopoulou K, Lambert SB, Robertson BH, Cherry JD, Shapiro CN. 1996. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 334: 549–554. Medline
- Hildt E, Saher G, Bruss V, Hofschneider PH. 1996. The hepatitis B virus surface protein (LHBs) is a transcriptional activator. Virology 225: 235–239. Medline
- Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC. 1995. A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 21: 273–278. Medline
- Howard CR, Allison LMC. 1995. Hepatitis B surface antigen variation and protective immunity. Intervirology 38: 35–40. Medline
- Kaneko M, Uchida T, Moriyama M, Arakawa Y, Shikata T, Gotroh K, Mima S. 1995. Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J Med Virol 47: 204–208. Medline
- Karthigesu VD, Allison LMC, Fortuin M, Mendy M, Whittle HC, Howard CR. 1994. A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 75: 443–448. Medline
- Kidd-Ljunggren K, Öberg M, Kidd AH. 1995. The hepatitis B virus X gene: analysis of functional domain variation and the gene phylogeny using multiple sequences. J Gen Virol 76: 2119–2130. Medline
- Kremsdorf D, Garreau F, Duclos H, Thiers V, Schellekens H, Petit MA, Bréchot C. 1993. Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient. J Hepatol 18: 244–250. Medline
- Kwee L, Lucito R, Aufiero B, Schneider RJ. 1992. Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol 66: 4382–4389. Medline
- Lee H, Lee Y-H, Huh Y-S, Moon H, Yun Y. 1995. X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter. J Biol Chem 270: 31405–31412. Medline
- Lee PI, Chang LY, Lee CY, Huang LM, Chang MH. 1997. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 176: 427–430. Medline
- Lin HJ, Lai C, Lauder IJ, Wu P, Lau TK, Fong M. 1991. Application of hepatitis B virus (HBV) DNA sequence polymorphisms to the study of HBV transmission. J Infect Dis 164: 284–288. Medline
- Magnius LO, Norder H. 1995. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38: 24–34. Medline
- McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, Östberg L. 1992. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 15: 757–766. Medline
- Mimms L. 1995. Hepatitis B virus escape mutants: “pushing the envelope” of chronic hepatitis B virus infection. Hepatology 21: 884–887. Medline
- Moriyama K, Nakajima E, Hohjoh H, Asayama R, Okochi K. 1991. Immunoselected hepatitis B virus mutant. Lancet 337: 125.
- Murakami S, Cheong JH, Kaneko S. 1994. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 269: 15118–15123. Medline
- Norder H, Couroucé AM, Magnius LO. 1992. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 73: 3141–3145. Medline
- Norder H, Hammas B, Lee SD, Bile K, Couroucé AM, Mushahawar IK, Magnius LO. 1993. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 74: 1341–1348. Medline
- Okamoto H, Imai M, Shimozaki M, Hoshi Y, Iizuka H, Gotanda T, Tsuda F, Miyakawa Y, Mayumi M. 1986. Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes. J Gen Virol 67: 2305–2314. Medline
- Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M. 1988. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69: 2575–2583. Medline
- Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S. 1992. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 32: 264–268. Medline
- Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. 1983. The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucl Acids Res 11: 1747–1757.
- Ori A, Shaul Y. 1995. Hepatitis B virus enhancer binds and is activated by the hepatocyte nuclear factor 3. Virology 207: 98–106. Medline
- Orito E, Mizokami M, Ina Y, Moriyama EN, Kameshima N, Yamamoto M, Gojobori T. 1989. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci USA 87: 7059–7062.
- Osterhaus A, Voss MC, Balk A, de Man RA, Mouton JW, Rothbarth PH, Schalm SW, Tomaello AM, Niesters HGM, Verbrugh HA. 1998. Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures. J Heart Lung Transplant 17: 158–166. Medline
- Pollicino T, Pernice F, Campo S, Mesiti O, Misefari V, Pernice M, Raimondo G. 1996. Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. J Gen Virol 77: 1833–1836. Medline
- Qadri I, Maguire H, Siddiqui A. 1995. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA 92: 1003–1007. Medline
- Radziwill G, Tucker W, Schaller H. 1990. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 64: 613–620. Medline
- Raney AK, Le HB, McLachlan A. 1992. Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor. J Virol 66: 6912–6921. Medline
- Rehermann B, Pasquinelli C, Mosier SM, Chisari FV. 1995. Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J Clin Invest 96: 1527–1534. Medline
- Roll M, Norder H, Magnius LO, Grillner L, Lindgren V. 1995. Nosocomial spread of hepatitis B virus (HBV) in a haemodialysis unit confirmed by HBV DNA sequencing. J Hosp Infect 30: 57–63. Medline
- Santantonio T, Jung MC, Pastore G, Angarano G, Günther S, Will H. 1997. Familial clustering of HBV pre-C and pre-S mutants. J Hepatol 26: 221–227. Medline
- Sterneck M, Günther S, Santantonio T, Fischer L, Broelsch CE, Greten H, Will H. 1996. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology 24: 300–306. Medline
- Sterneck M, Günther S, Gerlach J, Naoumov NV, Santantonio T, Fischer L, Rogiers X, Greten H, Williams R, Will H. 1997. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol 26: 754–764. Medline
- The Incident Investigation Teams and Others. 1997. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 336: 178–184. Medline
- Tindall KR, Kunkel TA. 1988. Fidelity of DNA synthesis by Thermus aquaticus DNA polymerase. Biochemistry 27: 6008–6013. Medline
- Uy A, Wunderlich G, Olsen DB, Heermann KH, Gerlich WH, Thomssen R. 1992. Genomic variability in the preS1 region and determination of routes of transmission of hepatitis B virus. J Gen Virol 73: 3005–3009. Medline
- Wallace LA, Echevarria JE, Echevarria JM, Carman WF. 1994. Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J Infect Dis 170: 1300–1303. Medline
- Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W, Thomas HC. 1992. Loss of the common “a” determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest 90: 2543–2547. Medline
- von Weizsäcker F, Pult I, Geiss K, Wirth S, Blum HE. 1995. Selective transmission of variant genomes from mother to infant in neonatal fulminant hepatitis B. Hepatology 21: 8–13. Medline
- Wu X, Zhu L, Li Z-P, Koshy R., Wang Y. 1992. Functional organization of enhancer (ENII) of hepatitis B virus. Virology 191: 490–494. Medline
- Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M. 1994. Naturally occurring escape mutants of hepatitis B virus with various mutations in the gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 68: 2671–2676. Medline
- Yuh CH, Chang YL, Ting LP. 1992. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol 66: 4073–4084. Medline
- Zuckerman MA, Hawkins AE, Briggs M, Waite J, Balfe P, Thom B, Gilson RJC, Tedder RS. 1995. Investigation of the hepatitis B virus transmission in a health care setting: application of direct sequence analysis. J Infect Dis 172: 1080–1083. Medline